계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Reforgene Medicine
company
About
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop drugs intended to cure genetic diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop new drugs intended to cure genetic diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Reforgene Medicine has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Sep 16, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 16, 2021 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Reforgene Medicine is funded by 1 investors.
China Merchants Securities
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
China Merchants Securities
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
